About the Company
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AKBA News
Q4 2022 Akebia Therapeutics Inc Earnings Call
David A. Spellman; Principal Accounting Officer, Senior VP, CFO & Treasurer; Akebia Therapeutics, Inc. John P. Butler; CEO, President & Director; Akebia Therapeutics ...
Akebia Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Business Highlights
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered ...
Akebia Therapeutics: Q4 Earnings Snapshot
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Thursday reported a loss of $7.6 million in its fourth quarter. On a per-share basis, the Cambridge ...
Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Ocean Biomedical, Inc. (NASDAQ: OCEA) shares climbed 62.3% to $7.61 after the company shared detailed research data ...
Akebia Therapeutics, Inc. (AKBA) Q4 2022 Earnings Call Transcript
Good day, ladies and gentlemen. Thank you for standing by and welcome to Akebia's Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Akebia Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Business Highlights
March 9, 2023 /PRNewswire/ -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today reported ...
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2022 Earnings Call Transcript
Operator: Good day ladies and gentlemen. Thank you for standing by and welcome to Akebia’s Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen ...
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2022 Earnings Call Transcript
David Spellman: Yes, so, Allie, thanks for the question. So like I said in the prepared remarks, we’re not going to provide the specific guidance, but we have done a lot of work to continue to ...
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2022 Earnings Call Transcript
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2022 Earnings Call Transcript March 9, 2023 Operator: Good day ladies and gentlemen. Thank you for standing by and welcome to Akebia's Fourth Quarter ...
Loading the latest forecasts...